Skip Navigation


European Heart Journal Advance Access originally published online on August 3, 2007
European Heart Journal 2007 28(17):2172; doi:10.1093/eurheartj/ehm125
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
28/17/2172    most recent
ehm125v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Egeland, T.
Right arrow Articles by Brinchmann, J. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Egeland, T.
Right arrow Articles by Brinchmann, J. E.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The European Society of Cardiology 2007. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

Cell quality in the ASTAMI study

Torstein Egeland

Section of Transplantation Immunology
Institute of Immunology
Rikshospitalet Medical Center
Sognsvannsveien 20
Oslo 0027
Norway

Jan E. Brinchmann

Ex Vivo Cell Laboratory
Institute of Immunology
Rikshospitalet Medical Center
Sognsvannsveien
Oslo 0027
Norway

Tel: +47 2307 1379 Fax: +47 2307 3780 E-mail address: torstein.egeland@rikshospitalet.no

The first 10% of the full text of this article appears below.

Schächinger et al.1 recently reported clinical improvement after treatment of acute myocardial infarction with intracoronary injection of autologous bone-marrow-derived mononuclear cells (MNCs) (the REPAIR-AMI Trial). Here, the authors discuss whether lack of improvement in global . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J Am Coll CardiolHome page
K. Lunde, S. Solheim, K. Forfang, H. Arnesen, L. Brinch, R. Bjornerheim, A. Ragnarsson, T. Egeland, K. Endresen, A. Ilebekk, et al.
Anterior myocardial infarction with acute percutaneous coronary intervention and intracoronary injection of autologous mononuclear bone marrow cells: safety, clinical outcome, and serial changes in left ventricular function during 12-months' follow-up.
J. Am. Coll. Cardiol., February 12, 2008; 51(6): 674 - 676.
[Full Text] [PDF]